Type 1 diabetes: From genetic predisposition to hypothetical environmental triggers;Le diabete de type 1: De la prédisposition génétique à un contexte environnemental hypothétique

Revue Medicale de Liege

Volumn 67, Issue 5-6, 2012, Pages 319-325

  Philips, J C ^a   Radermecker, R P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Autoimmunity; Environment; Genetics; HLA; Type 1 diabetes; Virus

Indexed keywords

FOOD TOXIN; INSULIN; TOXIN; UNCLASSIFIED DRUG;

ENVIRONMENTAL FACTOR; FOOD POISONING; GENETIC PREDISPOSITION; HLA SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; MILK; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; VIRUS INFECTION; VITAMIN D DEFICIENCY;

ANIMALS; DIABETES MELLITUS, TYPE 1; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; RISK FACTORS;

EID: 84863654917     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Todd JA. - Etiology of type 1 diabetes. Immunity, 2010, 32, 457-467.
2. Barnett A, Eff C, Leslie R, Pyke D. - Diabetes in identical twins. A study of 200 pairs. Diabetologia, 1981, 20, 87-93. (Pubitemid 11138466)
3. Pociot F, McDermott MF. - Genetics of type 1 diabetes mellitus. Genes Immun, 2002, 3, 235-249.
4. Patterson C, Dahlquist G, Gyürüs E, et al. - Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20 : a multicentre prospective registration study. Lancet, 2009, 373, 2027-2033.
5. Moutschen M. - Génétique, environnement et déterminisme des maladies auto-immunitaires. Rev Med Liège, 2012, 67, 263-272.
6. Lipponen K, Gombos Z, Kiviniemi M, et al. - Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes, 2010, 59, 3253-3256.
7. Weets I, Truyen I, Philips JC, Gorus F. - Diagnostic précoce et prévention du diabète de type 1 : rôle du Registre Belge du Diabète. Rev Med Liège, 2005, 60, 306-312. (Pubitemid 40941499)
8. Van der Auwera BJ, Schuit FC, Weets I, et al. - Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population : implications for future prevention studies. Hum Immunol, 2002, 63, 40-50. (Pubitemid 34074635)
9. Radermecker R, Scheen AJ, Letiexhe MR, et al. - Implications virales dans l'étiopathogénie du diabète de type 1: données actuelles. Rev Med Liège, 1998, 53, 597-602. (Pubitemid 28530647)
10. Geenen V. - La voie du thymus dans la physiopathologie et la prévention du diabète de type 1. Rev Med Suisse, 2005, 30, 1949-1953. (Pubitemid 44474852)
11. Boettler T, von Herrath M. - Protection against or triggering of Type 1 diabetes? Different roles for viral infections. Expert Rev Clin Immunol, 2011, 7, 45-53.
12. Vehik K, Dabelea D. - The changing epidemiology of type 1 diabetes : why is it going through the roof ? Diabetes Metab Res Rev, 2011, 27, 3-13.
13. Yeung WC, Rawlinson WD, Craig ME. - Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ, 2011, 342: d35. doi: 10.1136/bmj.d35
14. Dahlquist G. - The aetiology of type 1 diabetes : an epidemiological perpective. Acta Paediatr, 1998, 425, 5-10. (Pubitemid 28478142)
15. Knip M, Akerblom HK. - Environmental factors in the pathogenesis of type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes, 1999, 107, 93-100.
16. Pozzilli P, Manfrini S, Crino A, et al. - Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res, 2005, 37, 680-683. (Pubitemid 41810490)
17. Borkar VV, Devidayal, Verma S, Bhalla AK. - Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes, 2010, 11, 345-350.
18. Devaraj S, Yun JM, Duncan-Staley CR, et al. - Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am J Clin Pathol, 2011, 135, 429-433.
19. Cavalier E, Delanaye P, Souberbielle JC, Radermecker RP. - Vitamin D and type 2 diabetes mellitus: where do we stand? Diabetes Metab, 2011, 37, 265-272.
20. Wolden-Kirk H, Overbergh L, Christensen H, et al. -Vitamin D and diabetes : its importance for beta cell and immune function. Mol Cell Endocrinol, 2011, 347, 106-120.
21. Franck M, Paquot N, Scheen AJ. - Influence du poids corporel sur l'histoire naturelle et sur les approches thérapeutiques du diabète de type 1. Rev Med Liège, 2012, 67, sous presse.
22. Wilkin TJ. - The convergence of type 1 and type 2 diabetes in childhood The accelerator hypothesis. Pediatr Diabetes, 2011. doi: 10.1111/j.1399-5448. 2011.00831
23. Dahlquist G. - Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis. Diabetologia, 2006, 49, 20-24. (Pubitemid 43151608)
24. Dabelea D, D'Agostino RB Jr, Mayer-Davis EJ, et al. -Testing the accelerator hypothesis : body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care, 2006, 29, 290-294. (Pubitemid 44106506)
25. Philips JC, Scheen AJ, et le Registre Belge du Diabète. -Stratégies de prévention du diabète de type 1 : le point en 2003. Rev Med Liège, 2003, 58, 211-219.
26. Mathieu C, Keymeulen B. - Prévention du diabète de type 1 : essais chez la souris et chez l'homme. Rev Med Liège, 2005, 60, 303-305. (Pubitemid 40941498)
27. Mahon JL, Dupre J, Stiller CR. - Lessons learned from use of cyclosporin for insulin-dependent diabetes mellitus. The case for immunotherapy for insulin-dependent diabetics having residual insulin secretion. Ann N Y Acad Sci, 1993, 696, 351-363. (Pubitemid 24062807)
28. Gale E, Bingley P, Emmett C, et al. - European Nicotinamide Diabetes Intervention Trial (ENDIT) : a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet, 2004, 363, 925-931.
29. Philips JC, Scheen AJ, et le Registre Belge du Diabète. - Essai de prévention du diabète de type 1 par le nicotinamide : les leçons positives d'un essai clinique négatif (ENDIT). Rev Med Liège, 2002, 57, 672-675.
30. Diabetes Prevention Trial Type 1 Diabetes Study Group. -Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med, 2002, 346, 1685-1691.
31. Skyler J, Krischer J, Wolfsdorf J, et al. - Effects of oral insulin in relatives of patients with type 1 diabetes : the Diabetes Prevention Trial-Type 1. Diabetes Care, 2005, 28, 1068-1076. (Pubitemid 40616615)
32. Fourlanos S, Perry C, Gellert SA, et al. - Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes. Diabetes, 2011, 60, 1237-1245.
33. Philips JC, Keymeulen B, Mathieu C, Scheen AJ. - Anticorps monoclonaux en diabétologie : jusqu'au bout du rêve? Rev Med Liège, 2009, 64, 327-333.
34. Keymeulen B, Vandemeulebroucke E, Ziegler A, et al. -Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes. N Engl J Med, 2005, 352, 2598-2608. (Pubitemid 41007846)
35. Keymeulen B, Walter M, Mathieu C, et al. - Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia, 2010, 53, 614-623.
36. Ludvigsson J, Krisky D, Casas R, et al. - GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus. N Engl J Med, 2012, 366, 433-442.
37. TRIGR study group, Akerblom H, Krischer J, et al. - The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study : recruitment, intervention and follow-up. Diabetologia, 2011, 54, 627-633.
38. EURODIAB Substudy 2 Study Group. - Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia, 1999, 42, 51-54.
39. Hypponen E, Laara E, Reunanen A, et al. - Intake of vitamin D and risk of type 1 diabetes : a birth-cohort study. Lancet, 2001, 358, 1500-1503. (Pubitemid 33055701)